摘要
目的:探讨降钙素原在重症肺炎患者的诊断及预后的临床价值。方法选择30例确诊的重症肺炎患者(第一组)30例轻症肺炎患者(第二组)30例健康体检者(第三组)。确诊后当天2组患者均采静脉血做血培养及查降钙素原(PCT)及C反应蛋白(CRP),以PCT>0.5ng/ml为阳性诊断标准,所有患者均给予抗生素治疗,一周后复查PCT及CRP。结果第一组PCT(17.56±10.28),第二组PCT(8.85±3.32),第三组(0.21±0.15),差异有统计学意义。结论 PCT对重症肺炎病原学判别和诊疗中有重要临床价值,,值得临床推广应用。
bjective The aim of this study is to procalcitonin in diagnosis and prognosis of severe pneumonia patient.Methods 30 cases of severe pneumonia patient(No 1 group).30 cases Mild pneumonia patient(No 2 group).30 cases health examination(No 3group).After the diagnosis of the day two group patient Venous blood to blood culture and check procalcitonin and C-reactive protein.For what PCT>0.5ng/ml of the positive diagnostic criteria.All patient were given antibiotic therapy.Review PCT and CRP after a week.Results No1 group PCT(17.56±10.28)No 2 group PCT(8.85±3.32)No 3 group PCT(0.21±0.15),the difference was statistically significant.
作者
黄晓燕
Huang Xiaoyan(Yibin People's Hospital of Sichuan Province,644600)
出处
《临床研究》
2014年第8期16-16,共1页
Clinical Research
关键词
降钙素原
C反应蛋白
重症肺炎
procalcitonin
C-reactive protein
severe pneumonia